Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: A population-based study

[1]  T. Strandberg,et al.  Apathy: prevalence, associated factors, and prognostic value among frail, older inpatients. , 2012, Journal of the American Medical Directors Association.

[2]  B. Schmand,et al.  Symptoms of Apathy Are Associated with Progression from Mild Cognitive Impairment to Alzheimer’s Disease in Non-Depressed Subjects , 2012, Dementia and Geriatric Cognitive Disorders.

[3]  Constantine G Lyketsos,et al.  The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. , 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[4]  E G Tangalos,et al.  The incidence of MCI differs by subtype and is higher in men , 2012, Neurology.

[5]  N. Herrmann,et al.  The Role of Dopamine in Symptoms and Treatment of Apathy in Alzheimer's Disease , 2011, CNS neuroscience & therapeutics.

[6]  B. Yawn,et al.  American Journal of Epidemiology Practice of Epidemiology Use of a Medical Records Linkage System to Enumerate a Dynamic Population over Time: the Rochester Epidemiology Project , 2022 .

[7]  Jeannie-Marie S. Leoutsakos,et al.  Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction , 2011, International journal of geriatric psychiatry.

[8]  E G Tangalos,et al.  Prevalence of mild cognitive impairment is higher in men , 2010, Neurology.

[9]  W. Maier,et al.  Risk factors for incident mild cognitive impairment – results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe) , 2010, Acta psychiatrica Scandinavica.

[10]  C. Caltagirone,et al.  Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy. , 2010, Journal of Alzheimer's disease : JAD.

[11]  C. Jack,et al.  Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study. , 2010, Brain : a journal of neurology.

[12]  J. Jolles,et al.  Affective symptoms as predictors of Alzheimer's disease in subjects with mild cognitive impairment: a 10-year follow-up study , 2009, Psychological Medicine.

[13]  V. Pankratz,et al.  Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study. , 2008, Archives of general psychiatry.

[14]  V. Pankratz,et al.  The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics , 2008, Neuroepidemiology.

[15]  D. Bennett,et al.  Chronic distress and incidence of mild cognitive impairment , 2007, Neurology.

[16]  J. Morris,et al.  The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease Centers , 2006, Alzheimer disease and associated disorders.

[17]  V. Pankratz,et al.  Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. , 2006, Archives of neurology.

[18]  D. Bennett,et al.  Vitamin E and donepezil for the treatment of mild cognitive impairment. , 2005, The New England journal of medicine.

[19]  Olga V. Demler,et al.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[20]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[21]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[22]  D. Steffens,et al.  Apolipoprotein E genotype and major depression in a community of older adults. The Cache County Study , 2003, Psychological Medicine.

[23]  E. Tangalos,et al.  CME Practice parameter: , 2022 .

[24]  A. Schreiner.  Aggressive behaviors among demented nursing home residents in Japan , 2001, International journal of geriatric psychiatry.

[25]  E. Kaplan,et al.  The Boston naming test , 2001 .

[26]  J. Cummings,et al.  Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. , 2000, The Journal of neuropsychiatry and clinical neurosciences.

[27]  M. Szklo,et al.  Epidemiology: Beyond the Basics , 1999 .

[28]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[29]  E. Tangalos,et al.  Mayo's older Americans normative studies: category fluency norms. , 1998, Journal of clinical and experimental neuropsychology.

[30]  G. Schellenberg,et al.  Impact of Sample Selection on APOE ∈4 Allele Frequency: A Comparison of Two Alzheimer's Disease Samples , 1996 .

[31]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[32]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[33]  E. Tangalos,et al.  Mayo's Older Americans Normative Studies: Utility of corrections for age and education for the WAIS-R , 1992 .

[34]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[35]  James F. Malec,et al.  Mayo's older americans normative studies: WMS-R norms for ages 56 to 94 , 1992 .

[36]  E. Tangalos,et al.  The short test of mental status. Correlations with standardized psychometric testing. , 1991, Archives of neurology.

[37]  P. Costa,et al.  Personality in adulthood: a six-year longitudinal study of self-reports and spouse ratings on the NEO Personality Inventory. , 1988, Journal of personality and social psychology.

[38]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[39]  R. Reitan.  Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .

[40]  P. Sachdev,et al.  Neuropsychiatric symptoms in older people with and without cognitive impairment. , 2012, Journal of Alzheimer's disease : JAD.

[41]  C. Jack,et al.  Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. , 2004, Archives of neurology.

[42]  David A Bennett,et al.  Design of the Chicago Health and Aging Project (CHAP). , 2003, Journal of Alzheimer's disease : JAD.

[43]  E. Kokmen,et al.  Impact of referral bias on clinical and epidemiological studies of Alzheimer's disease. , 1996, Journal of clinical epidemiology.

[44]  R. Kessler,et al.  Sex and depression in the National Comorbidity Survey. II: Cohort effects. , 1994, Journal of affective disorders.

[45]  E. Tangalos,et al.  Mayo's older americans normative studies: WAIS-R norms for ages 56 to 97 , 1992 .

[46]  James F. Malec,et al.  Mayo's older americans normative studies: Updated AVLT norms for ages 56 to 97 , 1992 .

[47]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.